The finalized fiscal year (FY) 2021 ICD-10-CM and ICD-10-PCS code sets were recently released in the FY 2021 IPPS final rule, introducing new, revised, and deleted codes for diagnostic and procedural services and accompanying guideline changes.
Sarah Nehring, CCS, CCDS, RHIT, writes that acute blood loss anemia can increase expected reimbursement, the expected length of stay, and the severity of illness for an encounter. For these reasons, she presents seven things coders wish providers knew about accurately documenting this condition.
Encephalopathy affects nearly one in three novel coronavirus (COVID-19) patients, according to a recent study published in the Annals of Clinical and Translational Neurology.
Adrienne Commeree, CPC, CPMA, CCS, CEMC, CPIP, RHIA , examines the reporting for codes in Chapter 13, Diseases of the Musculoskeletal System and Connective Tissue, of the ICD-10-CM manual, which included infectious arthropathies, inflammatory polyarthropathies, osteoarthritis, and other joint disorders. Note : To access this free article, make sure you first register here if you do not have a paid subscription.
It’s more important than ever that organizations keep ahead of COVID-19 ICD-10-CM and MS-DRG audits and denials. The financial strain that many organizations are under makes it imperative that they minimize disruptions to revenue.
Q: CMS created a new MS-DRG for chimeric antigen receptor T-cell (CAR-T) therapies in the fiscal year (FY) 2021 IPPS final rule. Which ICD-10-PCS codes group to this new MS-DRG and does it qualify for an additional new technology add-on payment?
A few years ago, there was a change of attitude within seizure medicine that manifested itself as new terminology. The older term “pseudoseizure” was replaced by the phrase “psychogenic non-epileptogenic seizure.”
Valerie A. Rinkle, MPA, CHRI , reviews what providers need to know about the latest payment model from CMS’ Centers for Medicare and Medicaid Innovation.
The American Medical Association (AMA) released two new CPT codes October 7 for reporting antigen tests that detect the novel coronavirus (COVID-19) and influenza.
